Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Effectiveness of Duspatalin® (Mebeverine Hydrochloride) 200 mg b.i.d. in Patients With Post-cholecystectomy Gastrointestinal Spasm: a Post Marketing Observational Pro
Brief Summary: Prospective, multicenter, non-comparative, observational program designed to assess the effectiveness of a 2-6 weeks treatment with Duspatalin® 200mg BID and changes in quality of life in patients with post-cholecystectomy gastro-intestinal spasms